KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Evolent Health (EVH) Preferred Dividend Payments (2023 - 2025)

Evolent Health has reported Preferred Dividend Payments over the past 3 years, most recently at $6.1 million for Q3 2025.

  • For Q3 2025, Preferred Dividend Payments fell 25.06% year-over-year to $6.1 million; the TTM value through Dec 2025 reached $44.9 million, up 41.03%, while the annual FY2025 figure was $44.9 million, 41.03% up from the prior year.
  • Preferred Dividend Payments for Q3 2025 was $6.1 million at Evolent Health, down from $31.2 million in the prior quarter.
  • Over five years, Preferred Dividend Payments peaked at $31.2 million in Q2 2025 and troughed at $6.1 million in Q3 2025.
  • A 3-year average of $9.6 million and a median of $7.9 million in 2023 define the central range for Preferred Dividend Payments.
  • On a YoY basis, Preferred Dividend Payments climbed as much as 290.94% in 2025 and fell as far as 25.06% in 2025.
  • Year by year, Preferred Dividend Payments stood at $8.0 million in 2023, then decreased by 2.14% to $7.8 million in 2024, then fell by 22.36% to $6.1 million in 2025.
  • Business Quant data shows Preferred Dividend Payments for EVH at $6.1 million in Q3 2025, $31.2 million in Q2 2025, and $7.6 million in Q1 2025.